-+ 0.00%
-+ 0.00%
-+ 0.00%

REVIVA ANNOUNCES PUBLICATION ON CLINICAL VOCAL BIOMARKER DATA FROM THE RECOVER PHASE 3 CLINICAL TRIAL OF BRILAROXAZINE TO TREAT NEGATIVE SYMPTOMS IN SCHIZOPHRENIA

Reuters·01/08/2026 13:00:05

Please log in to view news